These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 32975406)

  • 1. Engineering of Cascade-Responsive Nanoplatform to Inhibit Lactate Efflux for Enhanced Tumor Chemo-Immunotherapy.
    Li K; Lin C; He Y; Lu L; Xu K; Tao B; Xia Z; Zeng R; Mao Y; Luo Z; Cai K
    ACS Nano; 2020 Oct; 14(10):14164-14180. PubMed ID: 32975406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanodrug regulates lactic acid metabolism to reprogram the immunosuppressive tumor microenvironment for enhanced cancer immunotherapy.
    Tian LR; Lin MZ; Zhong HH; Cai YJ; Li B; Xiao ZC; Shuai XT
    Biomater Sci; 2022 Jul; 10(14):3892-3900. PubMed ID: 35686599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor microenvironment responsive hollow mesoporous Co
    Huang J; Huang Y; Xue Z; Zeng S
    Biomaterials; 2020 Dec; 262():120346. PubMed ID: 32927232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In situ Engineering of Tumor-Associated Macrophages via a Nanodrug-Delivering-Drug (β-Elemene@Stanene) Strategy for Enhanced Cancer Chemo-Immunotherapy.
    Chen W; Li Y; Liu C; Kang Y; Qin D; Chen S; Zhou J; Liu HJ; Ferdows BE; Patel DN; Huang X; Koo S; Kong N; Ji X; Cao Y; Tao W; Xie T
    Angew Chem Int Ed Engl; 2023 Oct; 62(41):e202308413. PubMed ID: 37380606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binary regulation of the tumor microenvironment by a pH-responsive reversible shielding nanoplatform for improved tumor chemo-immunotherapy.
    Sun X; Zhang J; Zhao X; Yang C; Shi M; Zhang B; Hu H; Qiao M; Chen D; Zhao X
    Acta Biomater; 2022 Jan; 138():505-517. PubMed ID: 34798317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pH-sensitive tumor-tropism hybrid membrane-coated nanoparticles for reprogramming the tumor microenvironment and boosting the antitumor immunity.
    Zhang J; Wei L; Ma X; Wang J; Liang S; Chen K; Wu M; Niu L; Zhang Y
    Acta Biomater; 2023 Aug; 166():470-484. PubMed ID: 37253416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic reinforcement of immunogenic cell death and transformation of tumor-associated macrophages via an M1-type macrophage membrane-camouflaged ferrous-supply-regeneration nanoplatform.
    Wang Y; Xu H; Wang D; Lu Y; Zhang Y; Cheng J; Xu X; Chen X; Li J
    Acta Biomater; 2024 Jan; 174():358-371. PubMed ID: 38092253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumoral Lactate Depletion Based on Injectable Nanoparticles-Hydrogel Composite System Synergizes with Immunotherapy against Postablative Hepatocellular Carcinoma Recurrence.
    Chen Y; Bei J; Chen M; Cai W; Zhou Z; Cai M; Huang W; Lin L; Guo Y; Liu M; Huang X; Xiao Z; Xu Z; Zhu K
    Adv Healthc Mater; 2024 Mar; 13(6):e2303031. PubMed ID: 37848188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of glycolysis and lactate in the induction of tumor-associated macrophages immunosuppressive phenotype.
    Zhang Y; Zhang X; Meng Y; Xu X; Zuo D
    Int Immunopharmacol; 2022 Sep; 110():108994. PubMed ID: 35777265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic reprogramming by dual-targeting biomimetic nanoparticles for enhanced tumor chemo-immunotherapy.
    Zang S; Huang K; Li J; Ren K; Li T; He X; Tao Y; He J; Dong Z; Li M; He Q
    Acta Biomater; 2022 Aug; 148():181-193. PubMed ID: 35649505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomimetic Iron-Based Nanoparticles Remodel Immunosuppressive Tumor Microenvironment for Metabolic Immunotherapy.
    Zhang W; Li L; Wu Y; Li C; Xu Z; Zhang N; Wang X; Zhao Y; Zu T; He Q; Jiao J; Zheng R
    Int J Nanomedicine; 2024; 19():9333-9349. PubMed ID: 39286354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gold Cube-in-Cube Based Oxygen Nanogenerator: A Theranostic Nanoplatform for Modulating Tumor Microenvironment for Precise Chemo-Phototherapy and Multimodal Imaging.
    Zhang X; Xi Z; Machuki JO; Luo J; Yang D; Li J; Cai W; Yang Y; Zhang L; Tian J; Guo K; Yu Y; Gao F
    ACS Nano; 2019 May; 13(5):5306-5325. PubMed ID: 31018094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cascade Catalytic Nanoplatform Based on "Butterfly Effect" for Enhanced Immunotherapy.
    Shao Y; Wang Z; Hao Y; Zhang X; Wang N; Chen K; Chang J; Feng Q; Zhang Z
    Adv Healthc Mater; 2021 Apr; 10(8):e2002171. PubMed ID: 33448146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Hierarchical Structured Fiber Device Remodeling the Acidic Tumor Microenvironment for Enhanced Cancer Immunotherapy.
    Li Y; Yuan R; Luo Y; Guo X; Yang G; Li X; Zhou S
    Adv Mater; 2023 May; 35(21):e2300216. PubMed ID: 36912443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment.
    Yang M; Li J; Gu P; Fan X
    Bioact Mater; 2021 Jul; 6(7):1973-1987. PubMed ID: 33426371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
    Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
    Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Charge-switchable nanoparticles enhance Cancer immunotherapy based on mitochondrial dynamic regulation and immunogenic cell death induction.
    Zhao M; Li J; Liu J; Xu M; Ji H; Wu S; Chen D; Hu H
    J Control Release; 2021 Jul; 335():320-332. PubMed ID: 34062192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metal-Coordinated NIR-II Nanoadjuvants with Nanobody Conjugation for Potentiating Immunotherapy by Tumor Metabolism Reprogramming.
    Dai Y; Guo Z; Leng D; Jiao G; Chen K; Fu M; Liu Y; Shen Q; Wang Q; Zhu L; Zhao Q
    Adv Sci (Weinh); 2024 Sep; 11(34):e2404886. PubMed ID: 38973161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-β blockade-improved chemo-immunotherapy with pH/ROS cascade-responsive micelle via tumor microenvironment remodeling.
    Dai L; Li X; Zheng X; Fu Z; Yao M; Meng S; Zhang J; Han B; Gao Q; Chang J; Cai K; Yang H
    Biomaterials; 2021 Sep; 276():121010. PubMed ID: 34247042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ROS-augmented and tumor-microenvironment responsive biodegradable nanoplatform for enhancing chemo-sonodynamic therapy.
    An J; Hu YG; Cheng K; Li C; Hou XL; Wang GL; Zhang XS; Liu B; Zhao YD; Zhang MZ
    Biomaterials; 2020 Mar; 234():119761. PubMed ID: 31954230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.